H.R. 3988, The Generic Drug and Biosimilar User Fee Act of 2012
- This item is from the 112th Congress (2011-2012) and is no longer current. Comments, voting, and wiki editing have been disabled, and the cost/savings estimate has been frozen.
H.R. 3988 would amend the Federal Food, Drug, and Cosmetic Act to establish user-fee programs for generic drugs and biosimilars.
()
Learn More
RSS Feeds for This Bill
Keep yourself updated on user contributions and debates about this bill! (Learn more about RSS.)
Visitor Comments
There are currently no comments for this bill